The challenge of managing and mitigating impurities in drug products remains a critical focus with recent advancements in pharma. Impurities can pose serious health risks to patients and the presence of impurities can affect the safety, efficacy, stability, and the quality of the drugs. To understand the challenges faced by scientists and analytical R&D experts to rid of residual solvents, degradants, or process related impurities, this conclave facilitates knowledge sharing, best practices dissemination, and regulatory updates to ensure practical understanding of those aspects and encourages the highest standards of product quality and patient safety. Ultimately, the 2nd Annual Pharma Impurity Conclave 2024 by Eminence Business Media, scheduled for September 12th – 13that Hyderabad,serves as a critical platform for the industry professionals to address to those pressing needs for stringent impurity control in drug manufacturing.
2nd ANNUAL PHARMA IMPURITY CONCLAVE 2024
September 12th-13th, 2024 Sheraton Hyderabad Hotel
ABOUT THE EVENT
In response to the urgent concern plaguing the pharmaceutical industry, Eminence Business Media takes immense pride in announcing the highly anticipated 2nd Annual Pharma Impurity Conclave 2024, a symposium dedicated to solving the stubborn challenges by complying with the esteemed pharma fraternity. The paramount objective and recurring theme for the pharmaceutical sector shall forever be to uphold the safety and efficacy of medicinal compounds. In pursuit of these noble goals and in harmonious compliance with regulatory bodies, the global standards of the pharma industry have witnessed an unprecedented surge in R&D activities, fostering unparalleled quality benchmarks. The onus now lies on pharmaceutical professionals to shoulder the noble responsibility of delivering top-notch medications, transcending the boundaries of maladies and countries of focus. While the exhaustive evolution of medicines has led to remarkable breakthroughs, the R&D journey has also encountered numerous challenges, particularly concerning drug impurities. With the advent of various discoveries and synthesis processes, various contaminants have been observed in drug formulations, presenting an array of complex challenges and disputes. However, driven by unwavering determination, the resolute pharma industry has confronted this diversity with remarkable efficiency and precision. Nevertheless, 2018 had a new obstacle in store – NITROSAMINES, which remains the most prominent concern for the industry. Pharma Impurity Conclave 2023 aspires to surmount the most widely discussed challenges with unwavering efficacy, offering concrete solutions through in-depth exploration of the various layers of obstacles, thereby fortifying drug impurity profiling practices by evaluating their sources and processes. Though industry professionals are already familiar with multiple mechanisms of identification and risk assessment, the missing piece of the puzzle lies in quantifying uncertainty. From delving into practical case studies to comprehending the latest guideline updates, this meticulously curated program is designed to address the most recent and pressing challenges concerning impurity mechanisms, adopting cutting-edge and distinctive learning tools. Attendees will have the unique opportunity to learn from distinguished experts and apply their theoretical hypotheses in the stimulating Pharma Impurity Conclave 2023 setting. Thus, a new day brings forth another captivating program, wherein the timeless challenge is met with a fresh perspective and innovative approach, promising novel insights and solutions.
Addressing Key Challenges in Pharmaceutical Impurities
Pharmaceutical impurities, whether they arise during the manufacturing process or through degradation over time, can pose significant risks to patient safety. The regulatory landscape governing these impurities is complex and continually evolving. 2nd Annual Pharma Impurities Conclave 2024 aims to provide attendees with the latest insights and practical strategies to navigate these challenges effectively.
A Stellar Line-Up of Expert Speakers
The event will feature a distinguished line-up of speakers from regulatory bodies and leading pharma companies. By bringing together scientists, regulatory experts, and industry leaders, the conclave is to foster collaboration and innovation in impurity analysis, detection, and control strategies.
Key Topics and Sessions
Participants can look forward to a comprehensive agenda that covers a wide range of topics related to pharmaceutical impurities:
• Regulatory Updates: Detailed discussions on the latest guidelines from MHRA, FDA, EMA, and ICH, with a focus on permissible impurity levels and compliance requirements.
• Analytical Techniques: Sessions on cutting-edge analytical methods for detecting and quantifying impurities, including advancements in mass spectrometry and chromatography.
• Risk Assessment and Management: Expert-led discussions on risk assessment frameworks and best practices for managing impurities to ensure patient safety.
• Case Studies: Real-world examples of impurity identification, mitigation strategies, and successful regulatory submissions.
• Genotoxic Impurities: Special focus on the detection, evaluation, and control of genotoxic impurities, which can pose significant risks even at low levels.
Networking and Collaboration Opportunities
The conclave will also provide ample opportunities for networking and collaboration. Attendees can engage with peers, exchange ideas, and build professional relationships during dedicated networking sessions, panel discussions, and interactive workshops. The event aims to foster a collaborative environment where industry stakeholders can share knowledge and work together to advance the field of pharmaceutical quality control.
Join Us at the 2nd Annual Pharma Impurities Conclave 2024
Whether you are anAnalytical R&D professional, QC expert, or researcher in the pharma, the 2nd Annual Pharma Impurities Conclave 2024 is an event you won't want to miss. Join us to stay at the forefront of developments in pharmaceutical impurities, gain valuable insights from industry leaders, and contribute to the ongoing effort to ensure the safety and efficacy of drug products.
.png)
